Archive | Of Interest

Targeting melanoma cells with a drug-infused graphene matrix

Dr Livia Sima of the Institute of Biochemistry of the Romanian Academy and Dr Emanuel Axente of the National Institute for Laser, Plasma, and Radiation Physics in Romania are developing novel platforms for screening of therapeutic drug combinations for patients with metastatic melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

A Cure In Sight, in partnership with the UCSF Ocular Oncology Center and NORD, Launches Landmark Ocular Melanoma Natural History Study

Cleveland, OH, September 28, 2020—A Cure in Sight and the National Organization for Rare Disorders have launched an innovative study to research ocular melanoma, a disease that can cause blindness, loss of the eye and even death from spread to other organs.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Researchers Keep Cancer Cells Out by Blocking the Gate to the Nucleus

The nucleus of a cell is centrally important to an organism. It stores and organizes genetic information, while separating and protecting this very important information from the host of other cellular components.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Neoadjuvant, Adjuvant Data Provide Evidence of Curative Potential in Advanced Melanoma

Long-term data presented at the 2020 ASCO Virtual Scientific Program demonstrated sustained relapse-free survival (RFS) benefit with adjuvant therapy in patients with advanced melanoma, providing further evidence of the curative potential of postoperative therapy, explained Michael B. Atkins, MD.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest